Patents Assigned to UNIVERSITÉ DES ANTILLES
  • Insecticide properties of an extract of , and the constituents thereof
    Patent number: 10834926
    Abstract: The invention relates to the use of an extract of Sextonia rubra or the constituents thereof, rubrenolide and/or rubrynolide, as an insecticide agent against mosquitoes, especially as a larvicide agent.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: November 17, 2020
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS, INSTITUT PASTEUR, UNIVERSITÉ DE GUYANE, UNIVERSITÉ DES ANTILLES, GUYANE DÉVELOPPEMENT INNOVATION
    Inventors: Michaël Falkowski, Alice De Souza Rodrigues, Véronique Éparvier, Isabelle Dusfour, Emeline Houël, Didier Stien
  • Polypeptides and uses thereof for reducing CD95-mediated cell motility
    Patent number: 10556941
    Abstract: The present invention relates to polypeptides and uses thereof for reducing CD95-meditated cell motility. In particular, the present invention relates to a polypeptide having an amino acid sequence having at least 70% of identity with the amino acid sequence ranging from the amino-acid residue at position 175 to the amino-acid residue at position 191 in SEQ ID NO:1.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: February 11, 2020
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, UNIVERSITÉ DE BORDEAUX, UNIVERSITÉ DE RENNES, ECOLE DES HAUTES ETUDES EN SANTÉ PUBLIQUE (EHESP), UNIVERSITÉ DES ANTILLES ET DE LA GUYANE, INSTITUT BERGONIÉ, UNIVERSITY OF NOTTINGHAM
    Inventors: Patrick Legembre, Pierre Vacher, Doriane Sanseau, Aubin Penna, Robin Flynn
  • Polypeptides and uses thereof for reducing CD95-mediated cell motility
    Patent number: 10189887
    Abstract: The present invention relates to polypeptides and uses thereof for reducing CD95-meditated cell motility. In particular, the present invention relates to a polypeptide having an amino acid sequence having at least 70% of identity with the amino acid sequence ranging from the amino-acid residue at position 175 to the amino-acid residue at position 191 in SEQ ID NO:1.
    Type: Grant
    Filed: April 16, 2015
    Date of Patent: January 29, 2019
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE BORDEAUX, UNIVERSITE DE RENNES, ECOLE DES HAUTES ETUDES EN SANTE PUBLIQUE (EHESP), UNIVERSITE DES ANTILLES ET DE LA GUYANE, INSTITUTE BERGONIE, UNIVERSITY OF NOTTINGHAM
    Inventors: Patrick Legembre, Pierre Vacher, Doriane Sanseau, Aubin Penna, Robin Flynn
  • Fusion proteins and immunoconjugates and uses thereof which are specific for glycophorin A
    Patent number: 9879090
    Abstract: The present invention relates to isolated VHHs directed against human Glycophorin A. The present invention also relates to fusion proteins comprising the VHH according to the invention that is fused to at least one heterologous polypeptide and immunoconjugates comprising the VHH according to the invention that is conjugated to at least one chemical compound and their use in therapeutic or diagnostic methods.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: January 30, 2018
    Assignees: INSERM (Institut National De La SantéEt De La Recherche Médicale, Imoversité Paris Diderot—Paris 7, Universite Des Antilles Et De La Guyane, Institut National De La Transfusion Sanguine (INTS)
    Inventors: Olivier Bertrand, Ibrahim Habib, Dorota Smolarek
  • Methods and pharmaceutical compositions for treatment of retinal occlusion
    Patent number: 9463217
    Abstract: The present invention relates to methods and compositions for the treatment of retinal vein occlusion.
    Type: Grant
    Filed: February 8, 2013
    Date of Patent: October 11, 2016
    Assignees: Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Descartes—Paris V, Université Paris Diderot—Paris VII, Université des Antilles et de la Guyane, Institut National de la Transfusion Sanguinge (INTS), Assistance Publique—Hôpitaux de Paris, CHN OPHTALMOLOGIE QUINZE-VINGTS
    Inventors: Yves Colin Aronovicz, Olivier Hermine, Marie-Paule Wautier, Jean-Luc Wautier, Emmanuel Heron
  • Method for predicting the presence of reproductive cells in TESTIS
    Patent number: 9188582
    Abstract: Testicular germline markers and their use for predicting the presence or not of reproductive cells in testis of an infertile or hypo fertile male subject are provided. More particularly, identification of specific protein biomarkers of post-meiotic germ cells in the human seminal plasma was carried out by an integrative genomics approach. It was demonstrated that the presence of such biomarkers could be monitored in the seminal plasma of azoospermic subjects in order to select for a testis biopsy and testicular sperm extraction (TESE) only subjects for which there are high probabilities to find reproductive cells. The results indicate the analysis of seminal plasma is a non-invasive approach for predicting the presence of reproductive cells.
    Type: Grant
    Filed: October 31, 2012
    Date of Patent: November 17, 2015
    Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale), Université de Rennes 1, Université des Antilles et de la Guyane
    Inventors: Charles Pineau, Antoine Rolland, Pierre Calvel, Regis Lavigne